openPR Logo
Press release

Global Autoimmune Disease Diagnostic Market (By Disease, Tests Type, Regions), Key Company Profiles - Forecast to 2026

02-13-2020 08:25 PM CET | IT, New Media & Software

Press release from: ReportsnReports

Autoimmune Disease Diagnostic Market

Autoimmune Disease Diagnostic Market

This report titled "Global Autoimmune Disease Diagnostic Market (By Disease, Tests Type, Regions), Key Company Profiles - Forecast to 2026" provides a comprehensive analysis of the Global Autoimmune Disease Diagnostic Market.
The global autoimmune disease diagnostics market is expected to reach nearly US$ 18 Billion by 2026. Autoimmune diseases refer to a body's abnormal immune response leading to production of antibodies that attack own cells and tissues, causing deterioration and destruction of healthy tissues. Autoimmune diseases can be divided into two general groups: Organ specific, where the autoantibodies attack a specific organ, and Non-organ specific (or systemic), where the autoantibodies attack multiple organ systems. There are almost 80 types of autoimmune diseases prevailing worldwide including systemic lupus erythematosus or rheumatoid arthritis.

Download a FREE Sample Pdf Copy Of Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=2667888

As per the American Autoimmune Related Diseases Association, around 50 million Americans currently suffer from autoimmune related disorders. Moreover, the numbers are expected to escalate over the forecast period. The demand for better and precise diagnostic methods, along with the increasing prevalence, is expected to increase over the forecast period. The tests used to diagnose the autoimmune disease include auto antibody test, antinuclear antibody test, complete blood count, C-reactive protein, and erythrocyte sedimentation rate. Rising prevalence of diseases such as rheumatoid arthritis, Hashimoto's thyroiditis, and presence of favorable government regulations will render significant impact on the autoimmune disease diagnostics market growth.

By Disease - Global Autoimmune Disease Diagnostics Market and Forecast
o On the basis of disease, Localized autoimmune disease segment accounted for largest market share in 2018.
o Multiple sclerosis held highest share of the global localized autoimmune disease diagnostics market, followed by Inflammatory bowel disease segment.
o Type 1 Diabetes captured third highest share of the global localized autoimmune disease diagnostics market in 2018.
o Systemic autoimmune disease diagnostics segment will witness robust growth during the forecast timeframe.
o Rheumatoid Arthritis captured maximum share of the global systemic autoimmune disease diagnostics market in 2018, followed by Systemic lupus erythematosus (SLE).

By Tests Type - Global Autoimmune Disease Diagnostics Market and Forecast
o On the basis of test types, Autoantibody Test captured highest share of the overall autoimmune disease diagnostics market.
o The antinuclear antibodies (ANA) test captured second highest share of the global autoimmune disease diagnostics market in 2018.
o The complete blood count (CBC) is one of the most commonly ordered blood tests.
o Erythrocyte Sedimentation Rate Tests captured around 6% - 8% share of the global autoimmune disease diagnostics market followed by C -reactive protein test.
o Urinalysis Tests and Comprehensive Metabolic Panel Tests are competing closely with each other to grab maximum share of the pie.

By Region - Autoimmune Disease Diagnostics Market and Forecast
o North America currently dominates the global autoimmune disease diagnostics market and is expected to maintain its position throughout the forecast period.
o Globally, European region is the second-largest autoimmune disease diagnostics market.
o It is estimated that the prevalence rate of multiple sclerosis in Europe is 83 out of 100,000.
o Asia-Pacific autoimmune disease diagnostics market is expected to grow at the fastest rate during the forecast period.
o The Middle East & Africa and Latin America autoimmune disease diagnostics market is driven by the rising prevalence of autoimmune diseases and growing demand for better and accurate diagnostic procedures.

Please share your specific interest to serve you better | Download PDF Brochure at https://www.reportsnreports.com/contacts/requestsample.aspx?name=2667888

This 137 Page report with 66 Figures and 8 Tables has been analyzed from 7 View Points:
o Global Autoimmune Disease Diagnostics Market and Forecast (2011 - 2026)
o Global Autoimmune Disease Diagnostics Market Share and Forecast (2011 - 2026)
o By Disease - Global Autoimmune Disease Diagnostics Market and Forecast (2011 - 2026)
o By Test Type - Global Autoimmune Disease Diagnostics Market and Forecast (2011 - 2026)
o By Region - Autoimmune Disease Diagnostics Market and Forecast (2011 - 2026)
o Autoimmune Disease Diagnostics Market - Company Profiles
o Global Autoimmune Disease Diagnostics Market - Growth Drivers & Challenges

By Disease - Global Autoimmune Disease Diagnostics Market and Forecast
Systemic Autoimmune Disease Diagnostics Market
o Rheumatoid Arthritis
o Ankylosing Spondylitis
o Systematic Lupus Erythematosus
o Others Systemic Autoimmune Disease

Localized Autoimmune Disease Diagnostics Market
o Inflammatory Bowel Disease
o Multiple Sclerosis
o Type 1 Diabetes
o Hashimoto's Thyroiditis
o Others Localized Autoimmune Disease

By Test Type - Global Autoimmune Disease Diagnostics Market and Forecast
o Autoantibody Tests
o Antinuclear Antibody (ANA) Tests
o Complete Blood Count Tests
o Erythrocyte Sedimentation Rate Tests
o C- Reactive Protein (CRP) Tests
o Urinalysis Tests
o Comprehensive Metabolic Panel Tests
o Others Tests

By Region - Autoimmune Disease Diagnostics Market and Forecast
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East & Africa

Autoimmune Disease Diagnostics Market - Key Company Profiles, Strategy/Initiatives, Financial Insights
o Abbott Laboratories
o Siemens Healthineers
o Roche Diagnostics
o bioMerieux SA
o EUROIMMUN AG
o Bio-Rad Laboratories
o Quest Diagnostics

Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.

E-mail: sales@reportsandreports.com

Phone: +1 888 391 5441

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Autoimmune Disease Diagnostic Market (By Disease, Tests Type, Regions), Key Company Profiles - Forecast to 2026 here

News-ID: 1931909 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Disease

Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and